Kodiak Sciences Inc (KOD): Price and Financial Metrics


Kodiak Sciences Inc (KOD)

Today's Latest Price: $66.06 USD

0.19 (-0.29%)

Updated Jun 5 2:21pm

Add KOD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

KOD Daily Price Range
KOD 52-Week Price Range

KOD Stock Price Chart More Charts


KOD Price/Volume Stats

Current price $66.06 52-week high $82.75
Prev. close $66.25 52-week low $9.47
Day low $65.58 Volume 175,584
Day high $68.50 Avg. volume 356,352
50-day MA $54.58 Dividend yield N/A
200-day MA $44.81 Market Cap 2.94B

Kodiak Sciences Inc (KOD) Company Bio


Kodiak Sciences is a clinical stage biopharma specializing in therapeutics to treat chronic retinal diseases. The company was founded in 2005 and is based in New York City, New York.


KOD Latest News Stream


Event/TimeNews Detail
Loading, please wait...

KOD Latest Social Stream


Loading social stream, please wait...

View Full KOD Social Stream

Latest KOD News From Around the Web

Below are the latest news stories about Kodiak Sciences Inc that investors may wish to consider to help them evaluate KOD as an investment opportunity.

Top Small Cap Stocks for June 2020

Small cap stocks are listed companies that have market capitalizations typically ranging from $300 million to $2 billion. Since the share prices of these companies can have big fluctuations over a short period of time, companies with market caps of up to $10 billion are also found in the small cap universe. Small cap stocks, as represented by the Russell 2000 Index (RUT), have underperformed the broader market over the past 12 months.

Yahoo | May 29, 2020

Kodiak Sciences to Present at Upcoming Conferences

Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, announced today that management will present at the following upcoming virtual investor conferences:

Yahoo | May 28, 2020

Kodiak Sciences' Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Kodiak Sciences

Yahoo | May 26, 2020

Kodiak Sciences Inc. (KOD) Q1 2020 Earnings Call Transcript

KOD earnings call for the period ending March 31, 2020.

Yahoo | May 13, 2020

Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference

Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company developing novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that management will present at the virtual Bank of America Merrill Lynch Health Care Conference on Wednesday, May 13, 2020 at 11:20 a.m. Pacific Time (2:20 p.m. Eastern Time).

Yahoo | May 11, 2020

Read More 'KOD' Stories Here

KOD Price Returns

1-mo 19.98%
3-mo 3.35%
6-mo 2.47%
1-year 541.98%
3-year N/A
5-year N/A
YTD -8.19%
2019 913.38%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8446 seconds.